{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:11:16Z","timestamp":1793293876906,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key research and development program of Zhejiang Province","award":["2025C02089"],"award-info":[{"award-number":["2025C02089"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10067-025-07849-3","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:42Z","timestamp":1764720042000},"page":"1199-1207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Distinct phenotypes and prognosis between Jo-1 and non-Jo-1 subtypes in anti-synthetase syndrome: a retrospective cohort study from China"],"prefix":"10.1007","volume":"45","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-4197","authenticated-orcid":false,"given":"Yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"4-5","key":"7849_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","volume":"13","author":"M Mahler","year":"2014","unstructured":"Mahler M, Miller FW, Fritzler MJ (2014) Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev 13(4\u20135):367\u201371","journal-title":"Autoimmun Rev"},{"issue":"3","key":"7849_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1297-319X(03)00012-5","volume":"70","author":"A Imbert-Masseau","year":"2003","unstructured":"Imbert-Masseau A, Hamidou M, Agard C, Grolleau JY, Ch\u00e9rin P (2003) Antisynthetase syndrome. Joint Bone Spine 70(3):161\u2013168","journal-title":"Joint Bone Spine"},{"key":"7849_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1749-6632.2009.05119.x","volume":"1184","author":"AL Mammen","year":"2010","unstructured":"Mammen AL (2010) Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci 1184:134\u2013153","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"7849_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/BOR.0b013e3282f01a8c","volume":"19","author":"T Mimori","year":"2007","unstructured":"Mimori T, Imura Y, Nakashima R, Yoshifuji H (2007) Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol 19(6):523\u2013529","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"7849_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/BOR.0b013e328358bd85","volume":"24","author":"L Casciola-Rosen","year":"2012","unstructured":"Casciola-Rosen L, Mammen AL (2012) Myositis autoantibodies. Curr Opin Rheumatol 24(6):602\u2013608","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"7849_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jbspin.2006.04.005","volume":"73","author":"C Sordet","year":"2006","unstructured":"Sordet C, Goetz J, Sibilia J (2006) Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine 73(6):646\u2013654","journal-title":"Joint Bone Spine"},{"issue":"4","key":"7849_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060442","volume":"8","author":"Y Hamaguchi","year":"2013","unstructured":"Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M et al (2013) Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 8(4):e60442","journal-title":"PLoS One"},{"issue":"9","key":"7849_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1445-5994.2010.02164.x","volume":"41","author":"M Dugar","year":"2011","unstructured":"Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ (2011) Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies. Intern Med J 41(9):674\u2013679","journal-title":"Intern Med J"},{"issue":"8","key":"7849_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11926-013-0349-8","volume":"15","author":"B Hervier","year":"2013","unstructured":"Hervier B, Benveniste O (2013) Clinical heterogeneity and outcomes of antisynthetase syndrome. Curr Rheumatol Rep 15(8):349","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"7849_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12890-021-01399-5","volume":"21","author":"X Zhan","year":"2021","unstructured":"Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y et al (2021) Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China. BMC Pulm Med 21(1):57","journal-title":"BMC Pulm Med"},{"issue":"12","key":"7849_CR11","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/1756-185X.14428","volume":"25","author":"X Li","year":"2022","unstructured":"Li X, Zhou Q, Wu P, Chen Q, Ren Z, Yang X et al (2022) A prognostic analysis of antisynthetase syndrome-related interstitial lung disease. Int J Rheum Dis 25(12):1368\u201375","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"7849_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10067-022-06404-8","volume":"42","author":"R Wang","year":"2023","unstructured":"Wang R, Zhao Y, Qi F, Wu X, Wang Y, Xu Y et al (2023) Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China. Clin Rheumatol 42(3):703\u2013709","journal-title":"Clin Rheumatol"},{"issue":"7","key":"7849_CR13","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3899\/jrheum.161480","volume":"44","author":"J Shi","year":"2017","unstructured":"Shi J, Li S, Yang H, Zhang Y, Peng Q, Lu X et al (2017) Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies. J Rheumatol 44(7):1051\u20131057","journal-title":"J Rheumatol"},{"issue":"10","key":"7849_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","volume":"11","author":"I Marie","year":"2012","unstructured":"Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C et al (2012) Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11(10):739\u201345","journal-title":"Autoimmun Rev"},{"issue":"6","key":"7849_CR15","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","volume":"56","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Huapaya JA, Albayda J, Paik JJ, Johnson C et al (2017) A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies. Rheumatology (Oxford) 56(6):999\u20131007","journal-title":"Rheumatology (Oxford)"},{"key":"7849_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872615","volume":"13","author":"N Zhao","year":"2022","unstructured":"Zhao N, Jiang W, Wu H, Wang P, Wang X, Bai Y et al (2022) Clinical features, prognostic factors, and survival of patients with antisynthetase syndrome and interstitial lung disease. Front Immunol 13:872615","journal-title":"Front Immunol"},{"key":"7849_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","volume":"101","author":"Z Betteridge","year":"2019","unstructured":"Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper RG, New RP et al (2019) Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun 101:48\u201355","journal-title":"J Autoimmun"},{"issue":"8","key":"7849_CR18","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s10067-019-04503-7","volume":"38","author":"S Li","year":"2019","unstructured":"Li S, Ge Y, Yang H, Wang T, Zheng X, Peng Q et al (2019) The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies. Clin Rheumatol 38(8):2171\u20132179","journal-title":"Clin Rheumatol"},{"issue":"8","key":"7849_CR19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/art.1780230802","volume":"23","author":"M Nishikai","year":"1980","unstructured":"Nishikai M, Reichlin M (1980) Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum 23(8):881\u2013888","journal-title":"Arthritis Rheum"},{"issue":"1","key":"7849_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","volume":"52","author":"M Satoh","year":"2017","unstructured":"Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK (2017) A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 52(1):1\u201319","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"7849_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","volume":"13","author":"JC Lega","year":"2014","unstructured":"Lega JC, Fabien N, Reynaud Q, Durieu I, Durupt S, Dutertre M et al (2014) The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev 13(9):883\u201391","journal-title":"Autoimmun Rev"},{"issue":"6","key":"7849_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11926-013-0335-1","volume":"15","author":"A Ghirardello","year":"2013","unstructured":"Ghirardello A, Bassi N, Palma L, Borella E, Domeneghetti M, Punzi L et al (2013) Autoantibodies in polymyositis and dermatomyositis. Curr Rheumatol Rep 15(6):335","journal-title":"Curr Rheumatol Rep"},{"key":"7849_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200116","author":"M Honda","year":"2023","unstructured":"Honda M, Shimizu F, Sato R, Mizukami Y, Watanabe K, Takeshita Y et al (2023) Jo-1 antibodies from myositis induce complement-dependent cytotoxicity and TREM-1 upregulation in muscle endothelial cells. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000200116","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"7849_CR24","first-page":"269","volume":"42","author":"L Yang","year":"2024","unstructured":"Yang L, Zhang P, Yang Q, Zhang C, Guan W, Liu S (2024) Clinical features of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with macrophage activation syndrome. Clin Exp Rheumatol 42(2):269\u2013276","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"7849_CR25","first-page":"211","volume":"43","author":"X Liang","year":"2025","unstructured":"Liang X, Wu J, Ren H, Li M, Huang C, Guo JG et al (2025) Clinical features and prognosis of idiopathic inflammatory myopathies with coexistent multiple myositis-specific antibodies. Clin Exp Rheumatol 43(2):211\u2013220","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"7849_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103464","volume":"22","author":"OC Kilinc","year":"2023","unstructured":"Kilinc OC, Ugurlu S (2023) Clinical features of dermatomyositis patients with anti-TIF1 antibodies: a case based comprehensive review. Autoimmun Rev 22(12):103464","journal-title":"Autoimmun Rev"},{"key":"7849_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003121","author":"E Zanatta","year":"2023","unstructured":"Zanatta E, Cocconcelli E, Castelli G, Giraudo C, Fraia AS, De Zorzi E et al (2023) Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2023-003121","journal-title":"RMD Open"},{"issue":"6","key":"7849_CR28","first-page":"958","volume":"55","author":"JC Li","year":"2023","unstructured":"Li JC, Lai ZH, Shao M, Jin YB, Gao XJ, Zhang K et al (2023) Significance of anti-Jo-1 antibody\u2019s clinical stratification in idiopathic inflammatory myopathy and disease spectrum. Beijing Da Xue Xue Bao Yi Xue Ban 55(6):958\u201365","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"7849_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/art.41566","volume":"73","author":"T Gono","year":"2021","unstructured":"Gono T, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Ikeda K et al (2021) Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis\/dermatomyositis-associated interstitial lung disease. Arthritis Rheumatol 73(4):677\u201386","journal-title":"Arthritis Rheumatol"},{"key":"7849_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/648570","volume":"2013","author":"X Cen","year":"2013","unstructured":"Cen X, Zuo C, Yang M, Yin G, Xie Q (2013) A clinical analysis of risk factors for interstitial lung disease in patients with idiopathic inflammatory myopathy. Clin Dev Immunol 2013:648570","journal-title":"Clin Dev Immunol"},{"key":"7849_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032405","author":"G Cerro Chiang","year":"2023","unstructured":"Cerro Chiang G, Parimon T (2023) Understanding interstitial lung diseases associated with connective tissue disease (CTD-ILD): genetics, cellular pathophysiology, and biologic drivers. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24032405","journal-title":"Int J Mol Sci"},{"key":"7849_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.804034","volume":"13","author":"L Zhu","year":"2022","unstructured":"Zhu L, Cao Z, Wang S, Zhang C, Fang L, Ren Y et al (2022) Single-cell transcriptomics reveals peripheral immune responses in anti-synthetase syndrome-associated interstitial lung disease. Front Immunol 13:804034","journal-title":"Front Immunol"},{"issue":"1","key":"7849_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","volume":"73","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Cassidy E, Fertig N, Koontz DC, Lucas M, Ascherman DP et al (2014) Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 73(1):227\u201332","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"7849_CR34","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.rmed.2014.09.003","volume":"108","author":"C Johnson","year":"2014","unstructured":"Johnson C, Connors GR, Oaks J, Han S, Truong A, Richardson B et al (2014) Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type. Respir Med 108(10):1542\u20138","journal-title":"Respir Med"},{"issue":"11","key":"7849_CR35","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1007\/s10067-022-06291-z","volume":"41","author":"L Wen","year":"2022","unstructured":"Wen L, Chen X, Cheng Q, Nie L, Xu J, Yan T et al (2022) Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China. Clin Rheumatol 41(11):3419\u20133427","journal-title":"Clin Rheumatol"},{"issue":"10","key":"7849_CR36","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1136\/ard.2006.068502","volume":"66","author":"H Chinoy","year":"2007","unstructured":"Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG (2007) The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 66(10):1345\u20131349","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7849_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120313","volume":"10","author":"H Hozumi","year":"2015","unstructured":"Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y et al (2015) Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis\/dermatomyositis-associated interstitial lung disease: a retrospective case control study. PLoS One 10(3):e0120313","journal-title":"PLoS One"},{"issue":"3","key":"7849_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/08916930600623791","volume":"39","author":"R La Corte","year":"2006","unstructured":"La Corte R, Lo Mo Naco A, Locaputo A, Dolzani F, Trotta F (2006) In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity 39(3):249\u2013253","journal-title":"Autoimmunity"},{"issue":"7","key":"7849_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15261","volume":"27","author":"SB Ali","year":"2024","unstructured":"Ali SB, Hender L, Khoo T, Beroukas D, Griggs K, Limaye V (2024) Anti-synthetase syndrome in South Australia over 13 years: a clinical descriptive study. Int J Rheum Dis 27(7):e15261","journal-title":"Int J Rheum Dis"},{"key":"7849_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12216849","author":"T Sodsri","year":"2023","unstructured":"Sodsri T, Petnak T, Ngamjanyaporn P (2023) Clinical characteristics of anti-synthetase syndrome and variables associated with interstitial lung disease and mortality: a retrospective cohort study. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12216849","journal-title":"J Clin Med"},{"issue":"4","key":"7849_CR41","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.chest.2025.05.036","volume":"168","author":"R Imai","year":"2025","unstructured":"Imai R, Bermea RS, Zhao SH, Montesi SB, Singh A, Flashner BM et al (2025) Association of anti-Ro52 seropositive interstitial lung disease with a higher risk of disease progression and mortality. Chest 168(4):954\u2013966","journal-title":"Chest"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07849-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07849-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07849-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:03:00Z","timestamp":1769763780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07849-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7849"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07849-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All patients\u2019 data were used anonymously. This study was granted by the institute\u2019s ethical committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (approval number: 2020\u2013225). Given the retrospective nature of the investigation, informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have agreed to the publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}